e-learning
resources
Milan 2017
Tuesday, 12.09.2017
Idiopathic pulmonary fibrosis (IPF): treatment highlights
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - Six years experience of Pirfenidone treatment in IPF patients in Crete: Real life data
K. Karagiannis (Rhodes, Greece)
Source:
International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): treatment highlights
Session:
Idiopathic pulmonary fibrosis (IPF): treatment highlights
Session type:
Oral Presentation
Number:
3397
Disease area:
Interstitial lung diseases, Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Karagiannis (Rhodes, Greece). Late Breaking Abstract - Six years experience of Pirfenidone treatment in IPF patients in Crete: Real life data. 3397
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Late Breaking Abstract - Patients with severe eosinophilic asthma benefit from the treatment with Anti-IL-5 Reslizumab – a real life study from Austria
Source: International Congress 2018 – Notable Studies in Asthma
Year: 2018
Long-term (4 years) experience of Nintedanib in IPF patients in Crete: A real life data study
Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments
Year: 2018
Late Breaking Abstract - Early ICU physiotherapy on SARS-CoV-2 patients: A Spanish experience case series
Source: Virtual Congress 2020 – Novel findings in intensive care unit medicine: part 2
Year: 2020
Late Breaking Abstract - Idiopathic Pulmonary Fibrosis – a worldwide review of ‘real’ life’ practice: experience from a treatment feasibility review in 41 countries
Source: International Congress 2018 – ILDs: From bench to bedside
Year: 2018
Late Breaking Abstract - Real world patient-reported outcomes in asthma across six European countries: the NEWTON study
Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science
Year: 2021
Late Breaking Abstract - Initiation of patient enrollment in treatment with BPaL in Ukraine: first intermediate results
Source: Virtual Congress 2021 – Advances in the diagnosis of tuberculosis, multidrug-resistant tuberculosis and nontuberculous mycobacterial disease
Year: 2021
Late Breaking Abstract - Early follow-up of hospitalised and non-hospitalised patients with Covid-19 in a Swedish setting
Source: Virtual Congress 2021 – Challenges of COVID-19 management at short and long-term
Year: 2021
Late Breaking Abstract - Relationship between clinical features and mortality in a cohort of COPD patients.
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021
Late Breaking Abstract - Comparative analysis of effectiveness of Asthma Control Test-guided treatment versus usual care in patients with asthma from China
Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Year: 2020
Effectiveness evaluation of anti-IgE treatment at 3rd year: Real life Turkey data
Source: International Congress 2016 – Asthma points to ponder
Year: 2016
Late Breaking Abstract - Asthma control in preschool and subsequent disease remission
Source: International Congress 2019 – Asthma and the world
Year: 2019
Late Breaking Abstract - Identification of patients with COPD who benefit from benralizumab
Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: COPD and cough
Year: 2019
Late Breaking Abstract - International, prospective real-world study of mepolizumab in patients with severe asthma at one year: REALITI-A
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021
Late Breaking Abstract - Exercise rehabilitation in telemedicine for COVID-19 patients.
Source: Virtual Congress 2020 – Optimising the benefits of pulmonary rehabilitation
Year: 2020
Late Breaking Abstract - HRQol and other health related variables of Spanish COPD patients
Source: Virtual Congress 2020 – Interesting clinical problems for the respiratory physician
Year: 2020
Late Breaking Abstract - Detection of clinical instability by eNose in COPD patients
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
Late Breaking Abstract - Survival and course of lung function in patients with idiopathic pulmonary fibrosis with or without antifibrotic treatment: long-term results of the INSIGHTS-IPF registry
Source: International Congress 2019 – Idiopathic pulmonary fibrosis and surroundings
Year: 2019
Late Breaking Abstract - Determinants of disease control in patients with severe COPD. The CLAVE Study
Source: International Congress 2019 – Clinical approach to asthma management
Year: 2019
Late Breaking Abstract - Second Souffle: preliminary results from a national survey on the care pathways and quality of life of patients with T2 severe asthma
Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science
Year: 2021
Late Breaking Abstract - Prolonged azithromycin maintenance treatment in patients with COPD, a follow-up of the COLUMBUS trial
Source: International Congress 2019 – Blood eosinophils and more in airway diseases
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept